Managed Healthcare Executive October 3, 2023
Even though the Inflation Reduction Act will require plans to justify formulary placement of negotiated drugs, payers have more of an incentive to steer patients to lower-cost alternatives.
Medicare’s negotiation of prescription drugs could lead to increased access for Medicare patients. This is because of a little talked-about part of the Inflation Reduction Act requires all Medicare Part D plans to cover each of the selected drugs once the new prices go into effect in 2026. But it could also lead to increased use of payer utilization management efforts to rein in costs.
Two recent reviews look at this part of the law for its impact on patients and physicians. KFF suggests in its new analysis that Medicare’s effort to...
Today's Sponsors
Today's Sponsor